CLIA Waived LeadCare® II point-of-care system

The world's only CLIA-waived blood-lead system, LeadCare II improves clinical outcomes and is ideal for the physicians' offices, health clinics, or outreach-screening program.

Safe, fast, easy, and inexpensive to use, ESA developed LeadCare II with a grant from the U.S. Centers for Disease Control. No more waiting days for expensive lab analysis, or worrying about losing track of a child that needs follow-up care. LeadCare II delivers quantitative blood lead results equivalent to those reported by outside laboratories in just three minutes. It improves patient care by providing on-the-spot results, cuts your staffs' result-tracking and administrative time, and qualifies for reimbursement as a quantitative blood lead test (CPT code: 83655).

• Point-of-care results in just three minutes – eliminates multiple visits
• Simple to operate – no special training required
• Capillary samples (two drops, 50 ìl) – easier for patient, parent, and staff
• Accuracy and sensitivity you can count on – comparable to reference-lab tests
• Reimbursable – CPT code: 83655; per-test cost typically less than a reference-lab test

LeadCare II features:

• Small – 9.0 in x 6.5 in x 3.5 in
• Lightweight – 2.4 lbs
• Portable – runs on four AA battery or AC adapter
• One-touch electronic calibration
• All reagents and supplies provided in a convenient test kit – stable at room temperature
• Completely safe – unique gold electrode sensor contains no mercury or other toxic materials